Papers: 10.1371/journal.pmed.1002998

https://doi.org/10.1371/journal.pmed.1002998

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study

Cited by: 50
Author(s): Thomas Callender, Mark Emberton, Stephen Morris, Rosalind Eeles, Zsofia Kóte-Jarai, Paul D.P. Pharoah, Nora Pashayan
Published: over 6 years ago

Software Mentions 1